• Press Releases
• CRT in the news
• Events

Press Releases

• UK-NZ collaboration to home in on new anti-cancer drug for leukaemia - April 22 2010
• CRT announces partnership with Cephalon to develop a new class of anti-cancer drugs - March 19 2010
• Cancer Research UK and immatics Biotechnologies to trial vaccine for brain cancer - February 16 2010
• CRT and AstraZeneca form major alliance to create ‘cancer metabolism’ drugs - February 07 2010
• Development deal for PKB inhibitor announced - January 07 2010
• Deal struck for new investigational anti-cancer drug to target leukaemia and lymphoma - January 04 2010
• CRT grants rights for targeting technology to Aura - December 23 2009
• Scientists scoop top prize for light-based detection technology - December 10 2009
• CRT to licence Telomere targeting agents to Pharminox for Drug Development - October 13 2009
• CRT facilitates collaboration between Duke University and Cancer Therapeutics CRC - October 05 2009
• Cancer Research UK and AstraZeneca to accelerate biomarker research - October 05 2009
• New alliance for discovery of WNT pathway inhibitors to be used in cancer therapy - July 13 2009
• Initiation of global Phase III clinical study by Merck KGaA of Stimuvax® - June 22 2009
• Innovative partnership targets cancer-causing chaperones - June 07 2009
• Cambridge Research Institute attracts GSK backing for novel therapeutic collaboration - May 26 2009
• Cancer Research UK and GlaxoSmithKline join forces to trial new anti-cancer drug - May 20 2009
• CRT, Newcastle University and KuDOS advance DNA-PK Research with a new licence - May 15 2009
• Potential new drug blocks pathway of deadliest cancers - April 19 2009
• New deal boosts development of targeting peptides in nanotechnology - March 02 2009
• Temozolomide sales reach $1 billion - February 06 2009